Funder
National Natural Science Foundation of China
HKBU Strategic Development Fund
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Unraveling the allosteric inhibition mechanism of PARP-1 CAT and the D766/770A mutation effects via Gaussian accelerated molecular dynamics and Markov state model;Computers in Biology and Medicine;2024-01
2. Phthalimide‐tethered isatins as novel poly(ADP‐ribose) polymerase inhibitors: Design, synthesis, biological evaluations, and molecular modeling investigations;Archiv der Pharmazie;2023-12-15
3. Nanomedicine Combats Drug Resistance in Lung Cancer;Advanced Materials;2023-11-27
4. Discovery of novel 2,3,4,5-tetrahydrospiro[benzo[c]azepine-1,1’-cyclohexan]-5-ol derivatives as PARP-1 inhibitors;BMC Chemistry;2023-10-27
5. Discovery of Quinazoline-2,4(1H,3H)-dione Derivatives Containing a Piperizinone Moiety as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis;Journal of Medicinal Chemistry;2023-10-16